82 related articles for article (PubMed ID: 2251476)
1. [Concerning "risks and benefits of long-term treatment with estrogens" by T.M. Mack and R.K. Ross, Schweiz. med. Wschr. 1989; 119:1811-1820].
Sitruk-Ware R
Schweiz Med Wochenschr; 1990 Oct; 120(43):1608-10. PubMed ID: 2251476
[No Abstract] [Full Text] [Related]
2. Do risks of hormone therapy persist after discontinuation?
J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
[No Abstract] [Full Text] [Related]
3. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
4. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
5. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
Ribot C; Trémollieres F
Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
[TBL] [Abstract][Full Text] [Related]
6. A practical guide to prescribing estrogen replacement therapy.
Corson SL
Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
[TBL] [Abstract][Full Text] [Related]
7. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
[TBL] [Abstract][Full Text] [Related]
8. Practical guidelines for postmenopausal hormone therapy.
Speroff L; Kenemans P; Burger HG
Maturitas; 2005 May; 51(1):4-7. PubMed ID: 15883102
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
[No Abstract] [Full Text] [Related]
10. HRT, HERS, NIH, WHI: alphabet soup?
Legato MJ
J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
[No Abstract] [Full Text] [Related]
11. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
12. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
13. Is combined estrogen/progestogen hormone therapy worth the risk?
Sturdee DW; MacLennan AH
Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
[No Abstract] [Full Text] [Related]
14. Hormone replacement therapy and breast cancer risk.
Melnikow J
J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
[No Abstract] [Full Text] [Related]
15. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
16. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
17. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
18. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
Gambacciani M; Genazzani AR
Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
[No Abstract] [Full Text] [Related]
19. The risks and benefits of long-term estrogen replacement therapy.
Barrett-Connor EL
Public Health Rep; 1989; 104 Suppl(Suppl):62-5. PubMed ID: 2517703
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
